Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatsuki Fukami

Showing results (161-170 of 177) with videos related to

Pageof 18
Sort By:
Drug Metabolism and Pharmacokinetics|May 2, 2026
Regulatory impact of G-quadruplexes in the human carboxylesterase 2 gene on drug and lipid metabolismShintaro Kuroda, Shimon Nakashima, Seiya Takemoto, et al.
Biochemical Pharmacology|August 5, 2023
ncBAF enhances PXR-mediated transcriptional activation in the human and mouse liverKiamu Kurosawa, Masataka Nakano, Itsuki Yokoseki, et al.
Archives of Biochemistry and Biophysics|February 1, 2023
Identification of HSD17B12 as an enzyme catalyzing drug reduction reactions through investigation of nabumetone metabolismHiroyuki Ichida, Tatsuki Fukami, Takashi Kudo, et al.
International Journal of Cancer|September 22, 2006
CYP2A13 expressed in human bladder metabolically activates 4-aminobiphenylMiki Nakajima, Masahiro Itoh, Haruko Sakai, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 15, 2009
Quantitative analysis of UDP-glucuronosyltransferase (UGT) 1A and UGT2B expression levels in human liversTakeshi Izukawa, Miki Nakajima, Ryoichi Fujiwara, et al.
Drug Metabolism and Pharmacokinetics|June 6, 2025
Human aldo-keto reductase (AKR) 1C1 and 1C2 act as coactivators of pregnane X receptor, a master regulator of drug-metabolizing and gluconeogenesis enzymesRei Mitamura, Seiya Takemoto, Yuka Aoyama, et al.
Journal of Lipid Research|September 18, 2016
Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humansShogo Takahashi, Tatsuki Fukami, Yusuke Masuo, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 30, 2022
Quantitative Evaluation of the Contribution of Each Aldo-Keto Reductase and Short-Chain Dehydrogenase/Reductase Isoform to Reduction Reactions of Compounds Containing a Ketone Group in the Human LiverHiroyuki Ichida, Tatsuki Fukami, Keito Amai, et al.
Biochemical Pharmacology|November 19, 2021
Arylacetamide deacetylase knockout mice are sensitive to ketoconazole-induced hepatotoxicity and adrenal insufficiencyMai Nagaoka, Tatsuki Fukami, Fumiya Kisui, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 25, 2025
Three-dimensional-cultured renal tubular model reveals FXR-HNF4α-OAT1/3 axis as a target for preventing nucleotide analog-induced kidney injuryItsuki Yokoseki, Masataka Nakano, Etsushi Takahashi, et al.
Pageof 18

Showing results (161-170 of 177) with videos related to

Sort By:
Pageof 18
Drug Metabolism and Pharmacokinetics|May 2, 2026
Regulatory impact of G-quadruplexes in the human carboxylesterase 2 gene on drug and lipid metabolismShintaro Kuroda, Shimon Nakashima, Seiya Takemoto, et al.
Biochemical Pharmacology|August 5, 2023
ncBAF enhances PXR-mediated transcriptional activation in the human and mouse liverKiamu Kurosawa, Masataka Nakano, Itsuki Yokoseki, et al.
Archives of Biochemistry and Biophysics|February 1, 2023
Identification of HSD17B12 as an enzyme catalyzing drug reduction reactions through investigation of nabumetone metabolismHiroyuki Ichida, Tatsuki Fukami, Takashi Kudo, et al.
International Journal of Cancer|September 22, 2006
CYP2A13 expressed in human bladder metabolically activates 4-aminobiphenylMiki Nakajima, Masahiro Itoh, Haruko Sakai, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 15, 2009
Quantitative analysis of UDP-glucuronosyltransferase (UGT) 1A and UGT2B expression levels in human liversTakeshi Izukawa, Miki Nakajima, Ryoichi Fujiwara, et al.
Drug Metabolism and Pharmacokinetics|June 6, 2025
Human aldo-keto reductase (AKR) 1C1 and 1C2 act as coactivators of pregnane X receptor, a master regulator of drug-metabolizing and gluconeogenesis enzymesRei Mitamura, Seiya Takemoto, Yuka Aoyama, et al.
Journal of Lipid Research|September 18, 2016
Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humansShogo Takahashi, Tatsuki Fukami, Yusuke Masuo, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 30, 2022
Quantitative Evaluation of the Contribution of Each Aldo-Keto Reductase and Short-Chain Dehydrogenase/Reductase Isoform to Reduction Reactions of Compounds Containing a Ketone Group in the Human LiverHiroyuki Ichida, Tatsuki Fukami, Keito Amai, et al.
Biochemical Pharmacology|November 19, 2021
Arylacetamide deacetylase knockout mice are sensitive to ketoconazole-induced hepatotoxicity and adrenal insufficiencyMai Nagaoka, Tatsuki Fukami, Fumiya Kisui, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 25, 2025
Three-dimensional-cultured renal tubular model reveals FXR-HNF4α-OAT1/3 axis as a target for preventing nucleotide analog-induced kidney injuryItsuki Yokoseki, Masataka Nakano, Etsushi Takahashi, et al.
Pageof 18